How Biophysical Profiling Advances PROTAC Discovery
Targeted protein degradation (TPD) utilizing proteolysis-targeting chimeras (PROTACs) represents a promising therapeutic approach in modern drug discovery, according to recent technical disclosures. Rather than simply inhibiting disease-causing proteins, PROTACs leverage the cell’s natural protein disposal machinery to selectively eliminate them, creating opportunities to address targets traditionally considered undruggable, as outlined in technical notes from Novalix … Read more